Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYKE
3801
DELISTED
SYKES Enterprises Inc
SYKE
| $391K | ﹤0.01% |
13,389
+152
| +1% | +$4.5K |
|
3802
Hexcel
HXL
$7.82B
| $390K | ﹤0.01% |
6,801
-1,720
| -20% | -$92.7K |
|
3803
PUT
Compass Minerals
CMP
$1.15B
| $389K | ﹤0.01% |
6,000
+3,000
| +100% | +$200K |
|
3804
PUT
ProShares Ultra Silver
AGQ
$1.36B
| $388K | ﹤0.01% |
11,700
+11,300
| +2,825% | +$388K |
|
3805
Regional Management Corp
RM
$303M
| $388K | ﹤0.01% |
16,005
+13,511
| +542% | +$315K |
|
3806
Schneider National
SNDR
$6.25B
| $388K | ﹤0.01% |
15,332
+12,707
| +484% | +$282K |
|
3807
Kratos Defense & Security Solutions
KTOS
$11.4B
| $387K | ﹤0.01% |
29,535
+22,583
| +325% | +$278K |
|
3808
CALL
Lithia Motors
LAD
$8.26B
| $385K | ﹤0.01% |
3,200
+2,100
| +191% | +$220K |
|
3809
Universal Corp
UVV
$1.27B
| $385K | ﹤0.01% |
6,722
-4,601
| -41% | -$275K |
|
|
BEAT
3810
DELISTED
BioTelemetry, Inc.
BEAT
| $385K | ﹤0.01% |
11,678
-8,845
| -43% | -$306K |
|
|
EBIX
3811
PUT
DELISTED
Ebix Inc
EBIX
| $385K | ﹤0.01% |
5,900
-20,400
| -78% | -$1.18M |
|
3812
CALL
Infosys
INFY
$50.7B
| $384K | ﹤0.01% |
52,600
-2,000
| -4% | -$15.1K |
|
|
ARNA
3813
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $384K | ﹤0.01% |
15,105
+14,188
| +1,547% | +$325K |
|
3814
Cathay General Bancorp
CATY
$4.24B
| $383K | ﹤0.01% |
9,515
-617
| -6% | -$22.8K |
|
3815
Usana Health Sciences
USNA
$286M
| $383K | ﹤0.01% |
6,621
-23,195
| -78% | -$1.37M |
|
|
UNVR
3816
DELISTED
Univar Solutions Inc.
UNVR
| $383K | ﹤0.01% |
13,221
-30,098
| -69% | -$864K |
|
|
HNP
3817
DELISTED
Huaneng Power Intl, Inc.
HNP
| $383K | ﹤0.01% |
15,707
+307
| +2% | +$8.13K |
|
3818
Columbia Banking Systems
COLB
$8.84B
| $382K | ﹤0.01% |
9,081
-23,258
| -72% | -$899K |
|
3819
Four Corners Property Trust
FCPT
$2.75B
| $382K | ﹤0.01% |
15,300
+208
| +1% | +$5.21K |
|
3820
Forestar Group
FOR
$1.51B
| $381K | ﹤0.01% |
24,241
-50,877
| -68% | -$874K |
|
|
CMD
3821
DELISTED
Cantel Medical Corporation
CMD
| $381K | ﹤0.01% |
4,040
-274
| -6% | -$21.6K |
|
3822
PUT
Apollo Global Management
APO
$73.4B
| $379K | ﹤0.01% |
12,600
-18,000
| -59% | -$518K |
|
3823
CALL
Factset
FDS
$10.2B
| $378K | ﹤0.01% |
2,100
+1,800
| +600% | +$294K |
|
3824
Intrepid Potash
IPI
$469M
| $378K | ﹤0.01% |
8,659
+7,221
| +502% | +$244K |
|
3825
CALL
Insperity
NSP
$2.01B
| $378K | ﹤0.01% |
8,600
-800
| -9% | -$31.7K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.